Medlive Technology Co., Ltd. (HK:2192) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Medlive Technology Co., Ltd. reports a robust first half with a 40.3% increase in revenue and a 50.2% surge in profits for the six-month period ending June 30, 2024, compared to the previous year. The company’s profit attributable to its owners saw a 48.6% rise, while its adjusted net profit grew by 30.3%. The growth was primarily driven by a significant uptick in precision marketing and corporate solutions, which constitute 92.6% of total revenue.
For further insights into HK:2192 stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
- “The No. 1 Destination for the Most Talented Artists”: Netflix Stock (NASDAQ:NFLX) Notches Up as the Duffer Brothers Consider Jumping Ship
- “Breakthrough EVs”: Ford Stock (NYSE:F) Notches Up on New Battery Details
- “An Equity Stake”: Intel Stock (NASDAQ:INTC) Surges as U.S. Government May Buy In With CHIPS Act Money